Recursion pharmaceuticals

Index
Globenewswire

Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer

Globenewswire

Recursion Announces Plans to Open New Office in London

Globenewswire

Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline

Globenewswire

Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NVIDIA, and Updated Focus of Collaboration with Bayer to Precision Oncology

Globenewswire

Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery